The new guidelines have been written to help clinicians in the network follow clear, consistent and evidence-based referral pathways for patients with blood cancers. In doing so we will able to provide more consistent approaches to treatment and reduce unwarranted variations in care, ultimately helping to improve patient outcomes on a wider scale.
The guidelines may be accessed via the links below.
Pan London Acute Lymphoblastic Leukaemia (ALL) guidelines
Pan London Acute Myeloid Leukaemia (AML) guidelines
Pan London Chronic Myeloid Leukaemia (CML) guidelines
Pan London Chronic Lymphocytic Leukaemia (CLL) guidelines
Pan London Diffuse Large B-Cell Lymphoma (DLBCL) guidelines
Pan London Follicular Lymphoma (FL) guidelines
Pan London Hodgkin Lymphoma guidelines
Pan London Less Common Blood Cancer guidelines
Pan London Myelodysplastic Syndromes (MDS) guidelines